Overview
WST market data
Price History
WST price chart · 1M
- O
- 347.97
- H
- 352.80
- L
- 347.97
- C
- 350.17
- Vol
- 22,810.00
- Source
- US equities market feed
- Observed
- Aug 26, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $347.97
- Previous Close
- $348.50
- Day High
- $352.80
- Day Low
- $347.97
- 52 Week High
- $382.87
- 52 Week Low
- $228.08
- 7 Day Return
- -0.60%
- 30 Day Return
- +5.81%
- 90 Day Return
- +8.78%
- 1 Year Return
- +42.63%
- Daily Notional Volume
- $8M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 43.89 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.79 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.13 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.3% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 17.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $223.83 – $386.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $24.8B · P/B 6.23 · P/S 7.45.
Company News
Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock UpZacks Investment Research · Aug 27, 2026, 6:00 PM
Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $412Benzinga · Aug 3, 2026, 6:52 PM
Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $425Benzinga · Jul 27, 2026, 2:51 PM
West Pharmaceutical CEO Highlights GLP-1 And Biologics MomentumBenzinga · Jul 23, 2026, 3:32 PM
Full Transcript: West Pharmaceutical Servs Q2 2026 Earnings CallBenzinga · Jul 23, 2026, 1:22 PM
West Pharmaceutical Services shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates. Also, the company raised its FY26 guidance above estimates.Benzinga · Jul 23, 2026, 12:45 PM
8-K filing — WEST PHARMACEUTICAL SERVICES INC (WST)SEC EDGAR · Jul 23, 2026, 11:14 AM
Earnings Scheduled For July 23, 2026Benzinga · Jul 23, 2026, 11:11 AM
West Pharmaceutical Servs Raises FY2026 Adj EPS Guidance from $8.40-$8.75 to $8.85-$9.05 vs $8.61 Est; Raises FY2026 Sales Guidance from $3.295B-$3.350B to $3.345B-$3.380B vs $3.332B EstBenzinga · Jul 23, 2026, 10:09 AM
West Pharmaceutical Servs Raises FY2026 GAAP EPS Guidance from $8.15-$8.50 to $8.85-$9.05 vs $8.41 EstBenzinga · Jul 23, 2026, 10:08 AM